Events
ECTRIMS 2022 Amsterdam
Dr Wolf will attend the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 26-28 October 2022 in Amsterdam in person.
[...]
IMSCOGS 2019 Amsterdam
Dr Wolf attends the 2019 annual meeting of the International Multiple Sclerosis Cognition Society (IMSCOGS) in Amsterdam's Compagnietheater on 6 and 7 June.
[...]
AAN 2019 Philadelphia
Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 4-10 May 2019 in Philadelphia.
[...]
ECTRIMS 2016 London
Dr Wolf attends the congress of the European Committee on Treatment and Research in Multiple Sclerosis from 14-17 September 2016 at the Excel Convention Centre in London.
[...]
AAN 2016 Vancouver
Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 15-21 April 2016 in Vancouver.
[...]
ECTRIMS 2015 Barcelona
Dr Wolf attends the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 6-10 October 2015 at the Centre de Convencions Internacional in Barcelona.
[...]
AAN 2015 Washington
Dr Wolf's poster presentation at AAN:
Selmaj K, Barkhof F, Wolf C, Belova A, Oberyé JJL, van den Tweel ERW, Mulder R, Koper NP, Voortman G, Cohen JA. Similar Local Tolerability Profiles Following Double-Blind Treatment With Generic or Branded Glatiramer Acetate in Multiple Sclerosis (full text).
[...]
EMSP Briefing and Networking Event
On invitation of the Executive Committee of the advocacy organisation European Multiple Sclerosis Platform (EMSP), Dr Wolf attended a Briefing and Networking Event in downtown Brussels.
[...]
Joint ECTRIMS/ACTRIMS 2014 Boston
Dr Wolf attends the Joint Congress of the European and American Committee on Treatment and Research in Multiple Sclerosis from 10-13 October 2014 at the John B. Hynes Veterans Memorial Convention Center in Boston.
[...]
Joint Congress of European Neurology
Dr Wolf attended the Joint Congress of European Neurology from 31-May to 3-June-2014 in Istanbul.
[...]
Bionnale 2014 Berlin
Dr Wolf attended the Bionnale 2014 on 13-May-2014 in Berlin and represented Conelis e.V. during the Contact Forum.
[...]
EMA Workshop Multiple Sclerosis Guideline
Dr Wolf will attend the European Medicines Agency's Workshop on the clinical investigation of new medicines for the treatment of multiple sclerosis on 17 October 2013 in London.
[...]
Lecture on MS Drug Development (Düsseldorf)
Dr Christian Wolf was invited to lecture about MS drug development during the 15. Jahreskongress Klinische Pharmakologie on 10 October 2013 in Düsseldorf.
[...]
ECTRIMS 2013 Copenhagen
Dr Wolf will attend the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 1-5 October 2013 at the Bella Center in Copenhagen.
[...]
AAN 2013 San Diego
Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 16-23 March 2013 in San Diego.
[...]
BAPU 2012 Antwerpen
Dr Wolf attended the conference "Early Clinical Drug Development towards 2020" held by the Belgian Association of Phase I Units in Antwerp's Astrid Hotel on 9 November 2012.
[...]
ECTRIMS 2012 Lyon
Dr Wolf will attend the Congress of the European Committee on Treatment and Research in Multiple Sclerosis from 10-13 October 2012 in Lyon.
[...]
ENS 2012 Prague
Dr Wolf will attend the Annual Meeting of the European Neurological Society from 9-12 June 2012 in Prague.
[...]
AAN 2012 New Orleans
Dr Wolf will attend the Annual Meeting of the American Academy of Neurology from 21-28 April 2012 in New Orleans.
[...]
ECTRIMS 2011 Amsterdam
Dr Wolf will attend the Joint Triennial Congress of the European and Americas Committees on Treatment and Research in Multiple Sclerosis from 19-22 October 2011 in Amsterdam.
[...]Workshop FIM and Phase II (Berlin)
Dr Christian Wolf will speak at the workshop "Pharmaentwicklung: Erstanwendung am Menschen und Phase II" on 28 October 2011 in Berlin-Buch.
[...]
Drug-Related PML: Transatlantic Workshop
Dr Wolf will attend the Transatlantic workshop: drug-related progressive multifocal leukoencephalopathy from 25-26 July 2011 in London.
[...]